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Abstract
Hypokalaemic periodic paralysis (Hypo- 
PP) is characterised by transient attacks 
of muscle weakness o f varying duration 
and severity accompanied by a drop in 
serum potassium concentration during the 
attacks. The largest known HypoPP family 
is of Dutch origin and consists o f277 m em ­
bers in the last five generations 5 55 o f whom  
have HypoPP inherited in an autosomal 
dominant pattern. Forty-eight persons in­
cluding 28 patients with a proven diagnosis 
of HypoPP were used for linkage analysis. 
Micro satellite markers were used to ex­
clude 45 to 50% of the genome and linkage 
to chromosome lq31-32 was found. No 
recombinants were found between Hy­
poPP and D1S412 and a microsatellite 
contained within the DHP receptor a l 
subunit (CACLN1A3) gene. A previously 
reported G to A mutation causing an ar­
ginine to histidine substitution at residue 
528 in the transmembrane segment IIS4 of 
the CACLN1 A3 gene was shown in patients 
by restriction analysis o f genomic PCR  
products.
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myotonia,34 paramyotonia congenita,45 and
Hypokalaemic periodic paralysis (HypoPP) be­
longs to the group of familial periodic paralyses. 
These diseases are characterised by transient 
attacks of muscle weakness of varying duration 
and severity.1 Changes in serum potassium con­
centration during the attacks constitute the 
basis for subdividing periodic paralysis into 
hypo-, hyper-, and normokalaemic forms.1
T he genetic locus of the normokalaemic form 
in unknown. Hyperkalaemic periodic paralysis 
(HYPP) is characterised by attacks of flaccid 
muscular weakness as well as myotonia, which 
may even be the dominant symptom. M yotonia 
and paralysis may also occur in separate persons 
within the same family.2 This association has 
now been solved at the genetic level: HYPP 
both with and without myotonia or para­
atypical myotonia congenita6 are all known to 
result from mutations at various sites in the 
gene coding for the oc unit of the adult isoform 
of the skeletal muscle sodium channel 
(SCN4A) on chromosome 17q.367
HypoPP (MIM 170400) is the most frequent 
form of periodic paralysis. Although it is usually 
transmitted as an autosomal dominant disease, 
sporadic cases do occur.189 The initial attacks 
typically occur during the first two decades 
of life, sometimes increasing in frequency to 
weekly or even daily occurrences, but de­
creasing in frequency over the age of 30.10 
Perm anent muscular weakness on the basis of 
a vacuolar myopathy develops in some people 
and may lead to severe disability in older 
patients.1011 The pathophysiology of HypoPP 
has not been elucidated. An increased trans­
membrane conductance of N a +,1213 increased 
activity of the sodium potassium pum p,14 and 
faults in K + conductance1516 have been pro­
posed as the basic defect. However, even de­
tailed neurophysiological in vitro investigations 
of muscle fibres have not provided an adequate 
explanation.14
We were investigating the largest known Hy­
poPP family1011 for linkage when the as­
signment of the HypoPP locus to chromosome 
lq31-32  was published.17 The data of Fontaine 
e t a f1 suggest genetic homogeneity and the 
D H P receptor (calcium channel) alpha 1 sub­
unit (CACLN1A3) as a candidate gene and 
recent studies have indeed shown mutations in 
this gene.1819 In the present study we confirmed 
linkage to lq31—32 and were able to pinpoint 
a specific mutation in the CACLN1A3 gene.
Material and methods
PEDIGREE
The family has 277 members in the last five 
generations, 55 of whom have HypoPP.101120 
Forty-five affected persons were alive at the 
start of the investigations and 33 were per­
sonally investigated by one of the authors 
(TPL). Nineteen patients had typical attacks,
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Figure 1 The part o f the Dutch HypoPP fam ily used for linkage analysis. For a complete pedigree see Links et al 10 11
while 14 had muscle weakness without at­
tacks.11 T he diagnosis of HypoPP was based 
on clinical history, neurological examination 
and a reduced muscle fibre conduction ve­
locity.20 T he diagnosis was based on the clinical 
history and notes from other hospitals in the 
remaining cases and in dead patients.1011 The 
mean age of onset of attacks was 15*6 (range 
11-19) in men and 14*9 (range 9-18) in 
women. Forty-eight persons including 28 
patients^ all over the age of 20, were used for 
linkage analysis (fig 1). An autosomal dominant 
mode of inheritance was noted in the family. 
If the criteria m entioned above are used 
for diagnosisj the disease has complete 
penetrance,1011
DNA ANALYSIS
Blood samples were collected from 48 persons 
and genomic D N A  was isolated by phenol- 
chloroform extraction.21 Typing of mi­
crosatellite markers was performed as pre­
viously described.2223 Microsatellite markers 
from the D utch  Microsatellite Marker Col­
lection23 were used for the random gene search. 
For confirmation of linkage to chromosome 
lq 3 1 -3 2 5 the following markers were used: 
D1S158, D1S53, D 1S4123 D1S413, D1S249, 
and C A CN L1A 32425; prim er sequences are 
available through the H um an  Genome Data 
Base. P C R  reactions were done on 50 ng of 
template D N A  with a32P -C T P  in a volume 
of 15jil in 96 well microplates as previously
described23 except that end labelling of one 
of the primers was used for the CACNL1A3 
marker. After electrophoresis* the gels were 
dried and exposed overnight to x ray film
(Kodak X-AR).
LINKAGE ANALYSIS
Two point and multipoint lod scores were com­
puted with the LINKAGE program package 
version 5.10.2627 HypoPP was considered to 
be autosomal dominant with a penetrance of 
100%. The frequency of the gene in the general 
population was estimated as 0-0001.17
MUTATION SCREENING
The G to A mutation in codon 528 of die 
CACLN1A3 gene causes the loss of a £¿>^1 
restriction site.19 Genomic D N A  was amplified 
by PCR with the forward primer 5'-GGA-
G A TC C TG C TG G TG G A G TC G -3 ' and the
reverse primer 5 '-TC C TC A G G A G G C G G A - 
TGCAG-3' according to the protocol o f Jurkat- 
Rott et a/.10 After digestion with Bbvl3 the P C R  
products were run on a 15% polyacrylamide 
gel. Normal controls show two bands of 44 bp 
and 33 bp; mutants show an additional band 
of 77 bp, representing the undigestable PC R
product.
Results
At first, candidate regions containing ion chan­
nel or related genes were examined to exclude
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map o f chromosome lq . 
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Recombination fraction
Locus 0'00 0 ' 0 1 0'0S 0-10 0'20 0-30 0-40 Zmax Omax
D1S158 — 9-10 -3 -8 9 —1*87 -0 -8 0 0-21 0-44 0-29 0-44 0-30
D1S412 6-07 5'99 5-63 5*12 3-96 2-63 1-19 6-07 0-00
D1S413 0-33 0-67 1-47 1*58 1-22 0-68 0-22 1-59 0-09
D1S53 -4*93 -1 -7 4 — 0-46 -0*00 0-26 0-22 0-08 --------- --------
CACNL1A3 3-24 3-17 2’88 2'50 1-73 1-01 0-42 3-24 0-00
45 to 50% of the genome. Subsequent to the 
linkage finding of Fontaine et al,17 markers 
detecting the loci D1S4123 D1S413, and 
CACNL1 A3 (fig 2) were analysed in our family, 
resulting in convincing lod scores indicative of 
linkage. The maximum two point lod score 
(Zmax) between HypoPP and the chromosome 
lq  loci was 6*07 at a recombination fraction 
(0) of 0*00 from D1S412. The calcium channel 
CACNL1A3 was also linked to HypoPP: 
Zmax =  3*24 at 0max=O'OO (table). Multipoint 
analysis confirmed that the most likely location 
of the HypoPP gene is close to locus D1S412 
(fig 3). Haplotyping showed no recombinants 
between the HypoPP locus and markers
D1S412, D1S413, and CACNL1A3.
PCR amplification of genomic DNA was 
performed to screen for the recently found G 
to A mutation in codon 528 of the CACLN1 A3 
gene, causing loss of a Bbvl restriction site. All 
patients showed an additional 77 bp fragment 
of undigested amplification product (not 
shown)3 confirming the presence of this mut­
ation in this Dutch HypoPP family.
Discussion
Because this is the largest known family with 
HypoPP, our finding of linkage of HypoPP to 
chromosome lq31-32  strongly supports the 
data of Fontaine et aV1 T he penetrance of the 
gene defect appears to be complete^ although 
the age of onset varies and the clinical ma­
nifestation may be permanent and progressive 
muscle weakness instead of paralytic 
attacks.1011
8 00in CN 00  r — COLO
W COCO CO
r - f -
Q d o o
▼ T
a>
ooW
"Oo
Genetic distance from D1S412 (cm)
Figure 3 Multipoint analysis. Multipoint lod scores for the HypoPP locus with respect to 
chromosome lq markers are shown.
Haplotype analysis showed several re­
combinants between HypoPP and D 1S 158 and 
D 1S533 but not with D1S412 and the mi­
crosatellite located within the CACLN 1 A3 
gene. Recently Jurkat-Rott et al19 found a G to 
A mutation in the transmembrane segment 
IIS4 in several independent HypoPP patients. 
This mutation was also found in our Dutch
HypoPP family.
This particular calcium channel is an oli­
gomeric protein composed of two high m o­
lecular weight polypeptide subunits (a 1 and
2) and three smaller (3, y, and 5 units.2829 T h e  
a  1 units form the ion pore structure and also 
function as voltage sensors.3031 The gene is 
m utated in the muscular dysgenesis mouse 
(jndg), a lethal autosomal recessive disorder 
in which there is a total lack of excitation- 
contraction coupling in homozygotes.32
It is rather surprising to find a calcium chan­
nel gene defect implicated in the pa­
thophysiology of HypoPP. As referred to above 3 
most investigators have favoured other defects 
to explain the hypokalaemic attacks. N ev­
ertheless, early suggestions of disturbed Ca2+ 
release to the contractile elements33 and an 
enhanced deposition of Ca2+ in the sar- 
coplasmatic reticulum34 already suggested an 
inadequate release of calcium as the underlying 
defect in HypoPP.1011 Furthermore, the skeletal 
muscle calcium channels do play a key role 
in the excitation-contraction coupling.26 These 
findings might contribute to the understanding 
of the occurrence of paralysis in HypoPP. F u r­
ther studies need to be performed in order to 
elucidate the relationship between the calcium 
channel defect and the drop in serum K + con­
centration and the pathogenesis of permanent 
progressive muscle weakness.
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